Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn's disease

被引:37
作者
Kopylov, Uri [1 ]
Klang, Eyal [2 ,3 ]
Yablecovitch, Doron [1 ,3 ]
Lahat, Adi [1 ,3 ]
Avidan, Benjamin [1 ,3 ]
Neuman, Sandra [1 ,3 ]
Levhar, Nina [1 ,3 ]
Greener, Tomer [1 ,3 ]
Rozendorn, Noa [2 ,3 ]
Beytelman, Arkadi [2 ,3 ]
Yanai, Henit [4 ]
Dotan, Iris [4 ]
Chowers, Yehuda [5 ,6 ]
Weiss, Batya [3 ,7 ]
Ben-Horin, Shomron [1 ,3 ]
Amitai, Marianne M. [2 ,3 ]
Eliakim, Rami [1 ,3 ]
机构
[1] Sheba Med Ctr, Dept Gastroenterol, IL-52621 Tel Hashomer, Israel
[2] Sheba Med Ctr, Dept Diagnost Imaging, Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[4] Tel Aviv Univ, Dept Gastroenterol & Liver Dis, IBD Ctr, Tel Aviv Med Ctr,Sackler Fac Med, Tel Aviv, Israel
[5] Rambam Hlth Care Campus, Haifa, Israel
[6] Technion Israel Inst Technol, Bruce Rappaport Sch Med, Haifa, Israel
[7] Edmond & Lily Safra Childrens Hosp, Tel Hashomer, Israel
关键词
Crohn's disease; diffusion-weighted MRI; magnetic resonance enterography; videocapsule endoscopy; PILLCAM COLON 2(C); FECAL CALPROTECTIN; VALIDATION; INFLIXIMAB; THERAPY; RELAPSE; MARKER; SAFETY;
D O I
10.1177/1756283X16649143
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Video capsule endoscopy (VCE) and magnetic resonance enterography (MRE) are the prime modalities for the evaluation of small bowel (SB) Crohn's disease (CD). Mucosal inflammation on VCE is quantified using the Lewis score (LS). Diffusion-weighted (DW) magnetic resonance imaging (MRI) allows for accurate assessment of SB inflammation without administration of intravenous contrast material. The Magnetic Resonance Index of Activity (MaRiA) and the Clermont index are quantitative activity indices validated for contrast-enhanced MRE and DW-MRE, respectively. The aim of this study was to compare the quantification of distal SB inflammation by VCE and MR-related activity indices. Methods: Patients with known quiescent SB CD were prospectively recruited and underwent MRE and VCE. LS, MaRIA and Clermont scores were calculated for the distal SB. Results: Both MRI-based indices significantly correlated with the LS and the Clermont index (r = 0.50, p = 0.001 and r = 0.53, p = 0.001, respectively). Both MaRIA and Clermont scores were significantly lower in patients with mucosal healing (LS < 135). The area under the curve (AUC) with both MR scores was moderate for prediction of any mucosal inflammation (LS 135) and excellent for prediction of moderate-to-severe inflammation (LS 790) (0.71 and 0.74 versus 0.93 and 0.91 for MaRIA and Clermont score, respectively). Conclusions: Modest correlation between VCE- and MRE-based quantitative indices of inflammation in patients with quiescent SB CD was observed. Between-modality correlation was higher in patients with endoscopically severe disease. DW-MRE gauged by Clermont score was at least as accurate as contrast-enhanced MRE for quantification of SB inflammation.
引用
收藏
页码:655 / 663
页数:9
相关论文
共 30 条
[1]   European evidence based consensus for endoscopy in inflammatory bowel disease [J].
Annese, Vito ;
Daperno, Marco ;
Rutter, Matthew D. ;
Amiot, Aurelien ;
Bossuyt, Peter ;
East, James ;
Ferrante, Marc ;
Goetz, Martin ;
Katsanos, Konstantinos H. ;
Kiesslich, Ralf ;
Ordas, Ingrid ;
Repici, Alessandro ;
Rosa, Bruno ;
Sebastian, Shaji ;
Kucharzik, Torsten ;
Eliakim, Rami .
JOURNAL OF CROHNS & COLITIS, 2013, 7 (12) :982-1018
[2]   Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease [J].
Baert, Filip ;
Moortgat, Liesbeth ;
Van Assche, Gert ;
Caenepeel, Philip ;
Vergauwe, Philippe ;
De Vos, Martine ;
Stokkers, Pieter ;
Hommes, Daniel ;
Rutgeerts, Paul ;
Vermeire, Severine ;
D'Haens, Geert .
GASTROENTEROLOGY, 2010, 138 (02) :463-468
[3]   Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease [J].
Buisson, A. ;
Joubert, A. ;
Montoriol, P-F ;
Ines, D. D. ;
Hordonneau, C. ;
Pereira, B. ;
Garcier, J-M ;
Bommelaer, G. ;
Petitcolin, V. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (05) :537-545
[4]   Diffusion-Weighted Magnetic Resonance for Assessing Ileal Crohn's Disease Activity [J].
Caruso, Antonino ;
D'Inca, Renata ;
Scarpa, Marco ;
Manfrin, Paolo ;
Rudatis, Massimo ;
Pozza, Anna ;
Angriman, Imerio ;
Buda, Andrea ;
Sturniolo, Giacomo Carlo ;
Lacognata, Carmelo .
INFLAMMATORY BOWEL DISEASES, 2014, 20 (09) :1575-1583
[5]   PillCam COLON 2(C) in Crohn's disease: A new concept of pan-enteric mucosal healing assessment [J].
Carvalho, Pedro Boal ;
Rosa, Bruno ;
de Castro, Francisca Dias ;
Moreira, Maria Joao ;
Cotter, Jose .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (23) :7233-7241
[6]   Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease [J].
Costa, F ;
Mumolo, MG ;
Ceccarelli, L ;
Bellini, M ;
Romano, MR ;
Sterpi, C ;
Ricchiuti, A ;
Marchi, S ;
Bottai, M .
GUT, 2005, 54 (03) :364-368
[7]   Role of faecal calprotectin as non-invasive marker of intestinal inflammation [J].
Costa, F ;
Mumolo, MG ;
Bellini, M ;
Romano, MR ;
Ceccarelli, L ;
Arpe, P ;
Sterpi, C ;
Marchi, S ;
Maltinti, G .
DIGESTIVE AND LIVER DISEASE, 2003, 35 (09) :642-647
[8]  
Cotter J., 2014, ENDOSCOPY IN PRESS
[9]   Safety and Feasibility of Using the Second-Generation Pillcam Colon Capsule to Assess Active Colonic Crohn's Disease [J].
D'Haens, Geert ;
Lowenberg, Mark ;
Samaan, Mark A. ;
Franchimont, Denis ;
Ponsioen, Cyriel ;
van den Brink, Gijs R. ;
Fockens, Paul ;
Bossuyt, Peter ;
Amininejad, Leila ;
Rajamannar, Gopalan ;
Lensink, Elsemieke M. ;
Van Gossum, Andre M. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (08) :1480-+
[10]   Capsule Endoscopy Has a Significantly Higher Diagnostic Yield in Patients With Suspected and Established Small-Bowel Crohn's Disease: A Meta-Analysis [J].
Dionisio, Paula M. ;
Gurudu, Suryakanth R. ;
Leighton, Jonathan A. ;
Leontiadis, Grigoris I. ;
Fleischer, David E. ;
Hara, Amy K. ;
Heigh, Russell I. ;
Shiff, Arthur D. ;
Sharma, Virender K. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (06) :1240-1248